This research identifies androgen signaling as the primary driver behind the increased frequency and severity of posterior fossa type A (PFA) ependymoma in male children. By analyzing single-cell RNA sequencing data from both human tumors and developing mouse hindbrains, scientists discovered that male gliogenic progenitors remain in a less differentiated, more stem-like state compared to those in females. This developmental delay, fueled specifically by testosterone rather than sex chromosomes, creates a larger window for cancerous transformation and promotes aggressive tumor growth. Experiments demonstrated that androgen supplementation accelerates PFA cell proliferation, while androgen blockade effectively reduces the stemness and expansion of these malignant cells. Consequently, the study suggests that anti-androgen therapies could provide a vital new clinical strategy for treating this high-risk childhood brain cancer.

References:

• Zhang J, Ong W, Rasnitsyn A, et al. Androgen activity in the male embryonic hindbrain drives lethal PFA ependymoma[J]. Nature, 2026: 1-11.